Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 228 for “"Tacrolimus"”.
-
Tacrolimus
… Herausforderung für den behandelnden Arzt dar. Tacrolimus (Protopic®) ist ein Arzneistoff aus der Gruppe der Immunmodulatoren oder Calcineurinantagonisten, der alternativ zu den Glucocorticoiden beim atopischen Ekzem bzw. der atopischen Dermatitis verwendet wird. Das Ziel der vorliegenden Arbeit …
-
Tacrolimus oder Ciclosporin A
… MMF-Dosierung in Kombination mit Tacrolimus (Tac) bzw. Ciclosporin (CsA) in der immunsuppressiven Therapie nach Herztransplantationen effektiver sein würde. 60 Patienten (Tac n=30; CsA n=30) wurden nach Herztransplantation randomisiert auf beide Untersuchungsgruppen verteilt. Die …
-
Tacrolimus pharmacogenomics in abdominal solid organ transplantation
… of calcineurin inhibitor immunosuppression. Tacrolimus is the most widely used calcineurin inhibitor but has a narrow therapeutic range which requires close drug monitoring to prevent both toxicity and inadequate immunosuppression. Previous studies in renal transplantation have shown that …
-
Genetics of tacrolimus pharmacokinetics and kidney transplant outcomes
Tacrolimus (TAC) is the mainstay of current immunosuppressive therapy following kidney transplantation. However, TAC pharmacokinetics (PK) are highly variable and excessive high and low whole blood trough TAC concentrations (TAC C0) have been associated with toxicity and acute rejection, …
-
Individualising tacrolimus therapy in adult heart transplant recipients
Tacrolimus is the key immunosuppressant used in most solid-organ transplant recipients, including heart transplants, to prevent graft rejection. However, tacrolimus dosing strategies are complicated by the narrow therapeutic window and considerable pharmacokinetic variability. Individualising …
-
Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients
… the population pharmacokinetics (PK) of tacrolimus (Tac) (FK506) in the local Asian liver transplant recipients so as to identify possible relationships between clinical covariates and population parameter estimates using the NONMEM program. This can be achieved by (A) determining the …
-
Tacrolimus is not Neuroprotective Against Bilirubin Induced Auditory Impairment
In newborns, unconjugated bilirubin (UCB) is not readily excreted, and when bilirubin levels exceed the serum albumin binding capacity, pathological levels of UCB exist. Hyperbilirubinemia may lead to auditory damage and ultimately cause a hearing disorder called auditory neuropathy/dys-synchrony, …
-
Die C/D Ratio von Tacrolimus bei nierentransplantierten Patienten
… Medikamentenwirkungen. Zur Abschätzung des Tacrolimusbedarfs und des Metabolisierungsstatus könnte die Konzentration/Dosis-Ratio (C/D-Ratio) von Tacrolimus dienen. Ziel dieser Studie war es, die Veränderung der C/D-Ratio im ersten Jahr nach Transplantation zu untersuchen, sowie Einflüsse auf …
-
Farmacogenética do tacrolimus em pacientes pediátricos de transplante hepático
Introdução: tacrolimus (TAC) é uma droga imunossupressora amplamente utilizada após o transplante de órgãos sólidos para prevenir a rejeição. TAC tem uma janela terapêutica estreita entre subdose (que pode levar à rejeição de órgãos) e sobredose (que pode levar a efeitos adversos de toxicidade). A …
-
Pulmonary delivery of tacrolimus for lung transplant and asthma therapy
… rejection of allografted tissue. Introduction of tacrolimus, the most frequently prescribed calcineurin inhibitor, has lead to improved clinical outcomes for organ transplant recipients; however, little improvement has been noted in lung transplantation. Difficulties with current oral dosing …
-
Agouti Mice Models to Study the Diabetogenicity of FK506 (Tacrolimus)
… to high doses of an immunosuppressive drug tacrolimus (FK506) altered the secretion of insulin. The hypothesis of the present study is that FK506 treatment of transgenic mice, which either overexpress the agouti gene ubiquitously or in the adipose tissue, may alter expression of agouti mRNA …
-
Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients
… my K01 award Genetic Variants Associated with Tacrolimus (TAC) metabolism in Kidney Transplant Recipients. In Chapter 1, I discuss the significance and innovations of this project. In Chapter 2, I present reformatted manuscript published in the Pharmacogenomics Journal titled: Identification of …
-
Enhancement of peripheral nerve regeneration with controlled local release of Tacrolimus (FK506)
Despite substantial improvements in microsurgical techniques, patients with peripheral nerve injuries rarely recover fully. FK506, an FDA approved immunosuppressant, improves functional recovery and reinnervation following peripheral nerve injury in animal models. However, systemically delivered …
-
Untersuchung potentieller Wechselwirkungen der Immunsuppressiva Tacrolimus und Sirolimus auf den Lipidsenker Fluvastatin
… geprüft, ob die Kombination der Immunsuppressiva Tacrolimus bzw. Sirolimus mit dem Statin Fluvastatin einen Einfluss auf dessen Pharmakokinetik besitzt.
-
Frühe Vorhersage akuter und chronischer Abstoßung nach Dünndarmtransplantation in Tacrolimus behandelten Ratten
… Es erfolgte eine immunsuppressive Therapie mit Tacrolimus in unterschiedlicher Dosierung (0, 1, 3, 5 mg/kg KG). Zu definierten Zeitpunkten wurden Blutproben (-1, 0, 3, 5, 7, 14, 45 Tage) sowie Organproben (7, 14, 45) entnommen. CD3, Perforin, α-1,2-Mannosidase, TOAG-1 und B-Zell- IgG-Spiegel …
Page 1 of 12